Adicet Bio Inc ACET:NASDAQ

RT Quote | NASDAQ | USD
Last | 4:00 PM EST
16.40quote price arrow up+0.69 (+4.39%)
Volume
85,810
52 week range
6.02 - 21.70

...

Loading . . .

KEY STATS

  • Open15.72
  • Day High16.89
  • Day Low15.56
  • Prev Close15.71
  • 52 Week High21.70
  • 52 Week High Date07/17/20
  • 52 Week Low6.02
  • 52 Week Low Date03/19/20
  • Market Cap491.51M
  • Shares Out29.97M
  • 10 Day Average Volume0.36M
  • Dividend-
  • Dividend Yield-
  • Beta2.61
  • 1 Year % Change55.16

RATIOS/PROFITABILITY

  • EPS (TTM)-11.90
  • P/E (TTM)-1.38
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-57.80M
  • ROE (MRQ)-49.94%
  • Revenue (MRQ)12.49M
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-453.13%
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Adicet Bio Inc News

There is no recent news for this security.

Latest ACET News From Our Partners

QUOTE FINDER

Profile

MORE
Adicet Bio Inc., formerly resTORbio, Inc., is a biotechnology company. The Company is focused on developing allogeneic gamma delta T cell therapies for cancer and other diseases. It is developing a pipeline of off-the-shelf gamma delta T cells, engineered with chimeric antigen receptors and T cell receptor-like antibodies to enable selective tumor targeting, facilitate innate and adaptive anti-tumor immune response and improve persistence for durable activity in patients. Its...
Chen Schor CPA
President
Stewart Abbot Ph.D.
Chief Operating Officer
Don Healey Ph.D.
Chief Technology Officer
Address
500 Boylston St Fl 12
Boston, MA
02116-3740
United States